| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Letrozole, a new oral aromatase inhibitor for advanced breast cancer: double-blind randomized trial showing a dose effect and improved efficacy and tolerability compared with megestrol acetate.
|
J Clin Oncol
|
1998
|
3.69
|
|
2
|
Treatment of cancer with oral drugs: a position statement by the Spanish Society of Medical Oncology (SEOM).
|
Ann Oncol
|
2010
|
3.00
|
|
3
|
Phase II trial of first-line high-dose ifosfamide in advanced soft tissue sarcomas of the adult: a study of the Spanish Group for Research on Sarcomas (GEIS)
|
Ann Oncol
|
1998
|
1.60
|
|
4
|
Endobronchial metastatic disease: analysis of 32 cases.
|
J Surg Oncol
|
1996
|
1.40
|
|
5
|
[Corticoid treatment in Castleman's disease].
|
Med Clin (Barc)
|
1995
|
1.39
|
|
6
|
Multicenter phase II study of trabectedin in patients with metastatic castration-resistant prostate cancer.
|
Ann Oncol
|
2011
|
1.11
|
|
7
|
[Primary non-Hodgkin's lymphoma of the breast].
|
Med Clin (Barc)
|
1993
|
1.07
|
|
8
|
Comparative effectiveness of cisplatin-based and carboplatin-based chemotherapy for treatment of advanced urothelial carcinoma.
|
Ann Oncol
|
2011
|
1.05
|
|
9
|
Prospective study assessing hypoxia-related proteins as markers for the outcome of treatment with sunitinib in advanced clear-cell renal cell carcinoma.
|
Ann Oncol
|
2013
|
1.01
|
|
10
|
Node-negative breast cancers with p53(-)/HER2-neu(-) status may identify women with very good prognosis.
|
Anticancer Res
|
1996
|
0.95
|
|
11
|
Phase II trial of preoperative chemoradiotherapy with oxaliplatin, cisplatin, and 5-FU in locally advanced esophageal and gastric cancer.
|
Ann Oncol
|
2011
|
0.95
|
|
12
|
[EAU guidelines on prostate cancer. Part I: screening, diagnosis, and treatment of clinically localised disease].
|
Actas Urol Esp
|
2011
|
0.94
|
|
13
|
Gemcitabine and oxaliplatin combination: a multicenter phase II trial in unfit patients with locally advanced or metastatic urothelial cancer.
|
Ann Oncol
|
2007
|
0.94
|
|
14
|
Cavitary pulmonary metastases in transitional cell carcinoma of the urinary bladder.
|
Urol Int
|
1992
|
0.94
|
|
15
|
Prognostic time dependence of deletions affecting codons 557 and/or 558 of KIT gene for relapse-free survival (RFS) in localized GIST: a Spanish Group for Sarcoma Research (GEIS) Study.
|
Ann Oncol
|
2010
|
0.92
|
|
16
|
Sorafenib tolerability in elderly patients with advanced renal cell carcinoma: results from a large pooled analysis.
|
Br J Cancer
|
2013
|
0.91
|
|
17
|
Five-day course of granulocyte colony-stimulating factor in patients with prolonged neutropenia after adjuvant chemotherapy for breast cancer is a safe and cost-effective schedule to maintain dose-intensity.
|
J Clin Oncol
|
1996
|
0.88
|
|
18
|
Prostate cancer. Multidisciplinary approach: a key to success.
|
Crit Rev Oncol Hematol
|
2008
|
0.88
|
|
19
|
Addison's disease secondary to prostatic carcinoma. A case report.
|
Tumori
|
1990
|
0.88
|
|
20
|
Diagnostic value of bronchoalveolar lavage in peripheral lung cancer.
|
Am Rev Respir Dis
|
1993
|
0.88
|
|
21
|
[Spinal cord compression as a primary manifestation of occult thyroid carcinoma].
|
An Med Interna
|
1992
|
0.87
|
|
22
|
Discovery of myopodin methylation in bladder cancer.
|
J Pathol
|
2008
|
0.86
|
|
23
|
Mitogen-activated protein kinase phosphatase-1 (MKP-1) impairs the response to anti-epidermal growth factor receptor (EGFR) antibody cetuximab in metastatic colorectal cancer patients.
|
Br J Cancer
|
2010
|
0.86
|
|
24
|
[EAU guidelines on prostate cancer. Part II: treatment of advanced, relapsing, and castration-resistant prostate cancer].
|
Actas Urol Esp
|
2011
|
0.85
|
|
25
|
Usefulness of bone turnover markers as predictors of mortality risk, disease progression and skeletal-related events appearance in patients with prostate cancer with bone metastases following treatment with zoledronic acid: TUGAMO study.
|
Br J Cancer
|
2013
|
0.84
|
|
26
|
Late recurrent metastasis in Wilms' tumour.
|
Med Pediatr Oncol
|
1994
|
0.82
|
|
27
|
A multinational phase II trial of bevacizumab with low-dose interferon-α2a as first-line treatment of metastatic renal cell carcinoma: BEVLiN.
|
Ann Oncol
|
2013
|
0.81
|
|
28
|
Randomized phase III trials of second-line chemotherapy in patients with advanced bladder cancer: progress and pitfalls.
|
Ann Oncol
|
2011
|
0.81
|
|
29
|
p53 oncoprotein as a prognostic indicator in patients with breast cancer.
|
Anticancer Res
|
1998
|
0.80
|
|
30
|
A phase I, dose-finding study of sunitinib combined with cisplatin and 5-fluorouracil in patients with advanced gastric cancer.
|
Invest New Drugs
|
2012
|
0.79
|
|
31
|
Evaluation of treatment options for patients with advanced renal cell carcinoma: assessment of appropriateness, using the validated semi-quantitative RAND corporation/University of California, Los Angeles methodology.
|
Eur J Cancer
|
2012
|
0.79
|
|
32
|
Biochemical markers of bone turnover and clinical outcome in patients with renal cell and bladder carcinoma with bone metastases following treatment with zoledronic acid: The TUGAMO study.
|
Br J Cancer
|
2013
|
0.79
|
|
33
|
The impact of prior platinum therapy on survival in patients with metastatic urothelial cancer receiving vinflunine.
|
Br J Cancer
|
2013
|
0.78
|
|
34
|
Mitomycin-C and vinblastine in advanced breast cancer.
|
Oncology
|
1989
|
0.78
|
|
35
|
[Peripheral cholangiocarcinoma: results of surgical treatment].
|
Gastroenterol Hepatol
|
2006
|
0.77
|
|
36
|
Efficacy and safety of sorafenib in patients with advanced renal cell carcinoma with and without prior cytokine therapy, a subanalysis of TARGET.
|
Med Oncol
|
2009
|
0.77
|
|
37
|
Orbital metastases from transitional-cell cancer of the urinary bladder.
|
Urol Int
|
1991
|
0.76
|
|
38
|
Orbital metastasis, by transitional cell carcinoma of the bladder.
|
Int Urol Nephrol
|
1989
|
0.75
|
|
39
|
Nail-fold capillary microscopy and chemotherapy-induced vascular toxicity.
|
Ann Oncol
|
1991
|
0.75
|
|
40
|
Re: Adverse effect on bone marrow protection of prechemotherapy granulocyte colony-stimulating factor support.
|
J Natl Cancer Inst
|
1997
|
0.75
|
|
41
|
[Antineoplastic chemotherapy in digestive tumors].
|
Med Clin (Barc)
|
1991
|
0.75
|
|
42
|
Phase II trial of an all-oral regimen of tegafur and folinic acid in patients with previously treated metastatic breast cancer.
|
Cancer
|
1995
|
0.75
|
|
43
|
[Glycoprotein P and resistance to antitumor chemotherapy].
|
Med Clin (Barc)
|
1993
|
0.75
|
|
44
|
[Symptomatic hypomagnesemia in a patient treated with cisplatin].
|
Med Clin (Barc)
|
1990
|
0.75
|
|
45
|
[Acromegaly and lung cancer].
|
Rev Clin Esp
|
1989
|
0.75
|
|
46
|
[Bladder neoplasm in a patient with panarteritis nodosa treated with cyclophosphamide].
|
Rev Clin Esp
|
1992
|
0.75
|
|
47
|
Cytologic diagnosis in bronchoalveolar lavage specimens. A diagnostic technique for lung neoplasmas with a peripheral location.
|
Chest
|
1990
|
0.75
|
|
48
|
[Treatment with interferon of systemic Langerhans-cell histiocytosis in an adult].
|
Med Clin (Barc)
|
1990
|
0.75
|
|
49
|
[Epithelioid hemangioendothelioma of the liver].
|
Med Clin (Barc)
|
1990
|
0.75
|
|
50
|
[Metachronic squamous carcinoma of the tonsils to microcytic carcinoma of the esophagus].
|
Med Clin (Barc)
|
1990
|
0.75
|
|
51
|
[Regulatory proteins of the cell cycle: alterations in the cycline D1 pathway as a paradigm. Findings in breast cancer].
|
Med Clin (Barc)
|
1998
|
0.75
|
|
52
|
Nailfold capillary microscopy and bleomycin-induced vascular toxicity.
|
Cancer Invest
|
1990
|
0.75
|
|
53
|
Endobronchial metastases in colorectal adenocarcinoma.
|
Tumori
|
1992
|
0.75
|
|
54
|
Fatal septic thrombophlebitis due to Salmonella enteritidis.
|
Eur J Clin Microbiol Infect Dis
|
1989
|
0.75
|
|
55
|
[Pulmonary metastasising benign leiomyoma evolving to chronic respiratory failure].
|
Med Clin (Barc)
|
1997
|
0.75
|
|
56
|
Comparative study of sequential combinations of paclitaxel and methotrexate on a human bladder cancer cell line.
|
Cancer Invest
|
2000
|
0.75
|
|
57
|
Cyclophosphamide, methotrexate, and chronic oral tegafur modulated by folinic acid in the treatment of patients with advanced breast carcinoma.
|
Cancer
|
1998
|
0.75
|
|
58
|
Wilms' tumor in an adult patient.
|
Urol Int
|
1988
|
0.75
|
|
59
|
[Alternating chemotherapeutic treatment in patients with localized undifferentiated small-cell carcinoma of the lung].
|
Rev Clin Esp
|
1991
|
0.75
|
|
60
|
Malignant lymphoproliferative diseases in HIV-seropositive patients. A study of 40 cases at a single institution in Spain.
|
Acta Oncol
|
1995
|
0.75
|
|
61
|
[The clinical importance of the fibroblast growth factor (bFGF) as a biological marker and therapeutic modulator. Future applications].
|
Med Clin (Barc)
|
1996
|
0.75
|
|
62
|
Bone alkaline phosphatase serum level predicts the response to antiandrogen withdrawal.
|
Eur Urol
|
2002
|
0.75
|
|
63
|
[Solitary cerebellar metastases: a clinical neuro-radiological study].
|
Neurologia
|
1990
|
0.75
|
|
64
|
[Bilateral choroidal metastasis as a form of presentation of pulmonary carcinoma].
|
Med Clin (Barc)
|
1994
|
0.75
|
|
65
|
Life-threatening toxicity of oral tegafur-uracil (UFT) plus leucovorin.
|
Clin Oncol (R Coll Radiol)
|
1997
|
0.75
|
|
66
|
[Gene therapy: new prospects in the treatment of cancer].
|
Med Clin (Barc)
|
1994
|
0.75
|
|
67
|
Frequent dose delays and growth factor requirements with the sequential doxorubicin-CMF schedule.
|
Acta Oncol
|
1997
|
0.75
|
|
68
|
[The incidence of second neoplasms in advanced laryngeal cancer. Impact on survival].
|
Med Clin (Barc)
|
1994
|
0.75
|
|
69
|
Early results of the value of p53 in predicting survival in a homogeneous cohort of patients with invasive bladder cancer treated with a neoadjuvant carboplatin-based regimen (M-CAVI).
|
Tumori
|
1997
|
0.75
|